South Africa confirms third monkeypox case in tourist from Switzerland
A special ward for the isolation of suspected monkeypox cases, inside the Kasturba Hospital for Infectious Diseases in Mumbai, India, in May.
Keystone / Divyakant Solanki
South Africa has confirmed a third case of monkeypox, in a 42-year-old male tourist from Switzerland, the health department of the Limpopo province said.
This content was published on
1 minute
Reuters/ts
Español
es
Sudáfrica confirma tercer caso de viruela del mono en turista de Suiza
The tourist, who is holidaying in South Africa, presented with symptoms including a rash, muscle ache and fatigue. His infection was confirmed as monkeypox by South Africa’s National Institute for Communicable Diseases.
“Three contacts have already been identified and none of them has developed signs thus far,” Limpopo health official Phophi Ramathuba said in a statement.
Monkeypox is a viral disease that causes flu-like symptoms and skin lesions. It is endemic in parts of Africa, but not South Africa.
More than 50 countries where monkeypox is not endemic have reported outbreaks of the viral disease as confirmed cases exceed 7,600. Switzerland had 140 confirmed cases as of July 8.
More
More
Swiss confirm first case of monkeypox
This content was published on
Switzerland has detected its first case of monkeypox in canton Bern, health officials said on Saturday evening.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Monkeypox medication not authorised in Switzerland
This content was published on
Tecovirimat and the latest smallpox vaccine, which help against monkeypox, are not available in Switzerland, the NZZ am Sonntag reports.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.